Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001165527-16-000731
Filing Date
2016-04-14
Accepted
2016-04-14 12:54:07
Documents
1
Period of Report
2015-11-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3677
  Complete submission text file 0001165527-16-000731.txt   5118
Mailing Address 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address 65 YIGAL ALON STREET TEL AVIV L3 67433 011 972 3 562-1755
Cell Source, Inc. (Issuer) CIK: 0001569340 (see all company filings)

EIN.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELL SOURCE, INC. 65 YIGAL ALON STREET TEL AVIV L3 67433
Business Address
SHIMRAT ITAMAR (Reporting) CIK: 0001638324 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55413 | Film No.: 161571128